CMDB alumnus, Myriam Heiman, awarded NIH Director’s Transformative Research Award (TRA)

Myriam Heiman

CMDB program and Cunningham lab alumnus, Myriam Heiman, among one of the recipients of the 2021 NIH Director’s Transformative Research Award for her project titled, “Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND”. This prestigious award supports exceptionally innovative or unconventional research projects with the potential to create new scientific paradigms.

Congratulations to Dr. Heiman!

Read more about the 2021 TRA Recipients: https://commonfund.nih.gov/tra/recipients

Read more about Dr. Heiman’s research: https://heiman.mit.edu/myriam-heiman/